A clinical trial of estrogen-replacement therapy after ischemic stroke

New England Journal of Medicine

Volumn 345, Issue 17, 2001, Pages 1243-1249

  Viscoli, Catherine M ^a   Brass, Lawrence M ^a,b   Kernan, Walter N ^a   Sarrel, Philip M ^a   Suissa, Samy ^c   Horwitz, Ralph I ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PLACEBO;

AGED; ARTICLE; BREAST CANCER; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORTALITY; NEUROLOGIC DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SECONDARY PREVENTION; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DOUBLE-BLIND METHOD; ENDOMETRIUM; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; POSTMENOPAUSE; RECURRENCE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0035950682     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa010534     Document Type: Article

References (44)

1. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
2. Postmenopausal estrogen and prevention bias
3. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
4. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study
5. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women
6. Ovarian hormones and the circulation
7. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women
8. Risk of venous thromboembolism in users of hormone replacement therapy
9. Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study
10. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
11. Postmenopausal estrogen treatment and stroke: A prospective study
12. Mortality in a cohort of long-term users of hormone replacement therapy: An updated analysis
13. Decreased risk of stroke among postmenopausal hormone users: Results from a national cohort
14. Hormone replacement therapy and the risk of stroke: Follow-up of a population-based cohort in Sweden
15. Estrogen use and stroke risk in postmenopausal women
16. Estrogen use, hypertension and stroke in postmenopausal women
17. Risk of vascular disease in women: Smoking, oral contraceptives, noncontraceptive estrogens, and other factors
18. The role of estrogens as a risk factor for stroke in postmenopausal women
19. Stroke incidence and risk factors for stroke in Copenhagen, Denmark
20. The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women
21. Hormone replacement therapy and risk of non-fatal stroke
22. Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy
23. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50: The Framingham Study
24. Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses' Health Study
25. Estrogen after ischemic stroke: Clinical basis and design of the Women's Estrogen for Stroke Trial
26. Special report from the National Institute of Neurological Disorders and Stroke: Classification of cerebrovascular diseases III
27. Measurements of acute cerebral infarction: A clinical examination scale
28. Functional evaluation: The Barthel Index
29. A prognostic system for transient ischemia or minor stroke
30. Validation of the ACAS TIA/stroke algorithm
31. A simple method for determining the optimal dosage ofprogestin in postmenopausal women receiving estrogens
32. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents
33. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction: TIMI II A results
34. An improved approximate formula for calculating sample sizes for comparing two binomial distributions
35. A multiple testing procedure for clinical trials
36. Nonparametric estimation from incomplete observations
37. Evaluation of survival data and two new rank order statistics arising in its consideration
38. Regression models and life-tables
39. Compliance with hormone therapy
40. Compliance of women in taking estrogen replacement therapy
41. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
42. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)
43. Estradiol increases dendritic density by reducing GABA neurotransmission in hippocampal neurons
44. Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women